entrinsic bioscience

📍 Norwood, United States👥 28 employees💰 Last funded Jan 2020
Biotechnology Research🌐 entrinsicbioscience.com
Website LinkedIn
entrinsic bioscience (EBS) combines its proprietary IP platform and discovery engine to deliver next generation functional ingredients and Active Pharmaceutical Ingredients (APIs) designed to address multiple consumer health conditions and serious disease states. EBS was the first to discover that precise, patented combinations of small molecule amino acids can modulate targeted Epithelial Transmembrane Proteins (ETPs) via cell signaling. Through proprietary bio-mapping and electrophysiology techniques, EBS’ platform harnesses the body’s natural signaling mechanisms to protect, maintain, and restore health and wellness across a range of GI, respiratory, and skin conditions. Recent partnerships include leading OTC consumer health companies, the world’s largest CPG company, and a category leading global functional beverage company. EBS’ first commercialized product, enterade Advanced Oncology formula, is an oncology supportive care product clinically proven to significantly reduce the side effects of chemotherapy and radiation treatment. It has been used successfully by over 40,000 patients. For more information, please visit us at www.entrinsicbioscience.com
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in entrinsic bioscience?
entrinsic bioscience has 1 investors on record on gritt.io.
When did entrinsic bioscience last raise funding?
The most recent investment in entrinsic bioscience recorded on gritt.io was in January 2020.
What industry is entrinsic bioscience in?
entrinsic bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is entrinsic bioscience based?
entrinsic bioscience is headquartered in Norwood, United States.